Abstract:Budd-Chiari syndrome (BCS) is a relatively rare disease, most commonly found in middle-aged females, and is caused by hepatic vein blockage, except in Asian countries where it is more commonly found in males with inferior vena cava (IVC) obstruction.[1] The condition is classified as either primary or secondary depending on the source of the obstruction and whether it originates from within the venous system, such as in thrombosis, or external to the venous system, such as in compression by tumors of adjacent organs or polycystic kidney disease. Primary BCS is the most common manifestation and is most prevalent in those with underlying thrombogenic disorders such as primary myeloproliferative disease, essential thrombocythemia, and myelofibrosis.[2] Conditions that result in hypercoagulability such as pregnancy, oral contraceptive use, factor V mutation, antithrombin deficiency, protein C deficiency, and paroxysmal nocturnal hemoglobinuria can also cause primary BCS.[3] However, in most cases, the local cause of the thrombus formation cannot be identified. BCS generally becomes clinically evident after the occlusion of two or more major hepatic veins ([Figs. 1] and [2]). This causes a build-up of sinusoidal pressure and increased filtration of interstitial fluid into the liver capsule after the capacity of lymphatic drainage capacity has been exceeded. Resulting portal hypertension causes reduced hepatic blood flow and hepatocyte damage.[2] BCS and its progression can range in severity from asymptomatic, unobtrusive disease to acute, debilitating disease with significant morbidity.[4] [5] When symptomatic, BCS can present with abdominal pain and/or distention, ascites, hepatomegaly, jaundice, upper gastrointestinal bleeding, hepatic encephalopathy, and edema.[4] In chronic cases, patients can also present with renal impairment.[1] Article published online: 14 March 2024 © 2024. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

S4275 Triple Risk Factors for Budd-Chiari Syndrome

A Nationwide Analysis of Budd-Chiari Syndrome in the United States

S4263 Budd-Chiari Plus a Friend - A Case of Chronic Budd Chiari Syndrome and Simultaneous Superior Mesenteric Vein Thrombus

Budd-Chiari Syndrome Associated With Autoimmune Hemolytic Anemia, Immune Thrombocytopenic Purpura, and Lupus Nephritis: A Case Report

Staged Management of Budd-Chiari Syndrome Caused by Co-Obstruction of the Inferior Vena Cava and Main Hepatic Veins.

The Clinical Characteristics of 151 Cases of Budd-Chiari Syndrome

Prevalence of Prothrombotic Factors in Patients with Budd-Chiari Syndrome or Non-Cirrhotic Nonmalignant Portal Vein Thrombosis: A Hospital-Based Observational Study.

Budd-Chiari syndrome and its associated hepatocellular carcinoma: Clinical risk factors and potential immunotherapeutic benefit analysis

Advanced Imaging Techniques Used in Direct Portosystemic Shunt Creation in Budd-Chiari Syndrome with Complex Venous Anatomy

Liver cirrhosis caused by chronic Budd–Chiari syndrome

[Budd-Chiari syndrome and JAK2 gene mutation]

Bleeding in patients with Budd-Chiari syndrome

Point-of-care ultrasound in the diagnosis and treatment of Budd-Chiari syndrome: A rare case report and literature review

Discrimination between Budd-Chiari Syndrome,Hepatic Veno Occlusive Disease and Liver Cirrhosis

Analysis of Surgical Treatment Results in 120 Cases of Budd-Chiari Syndrome

Identification of potential genetic Loci and polygenic risk model for Budd-Chiari syndrome in Chinese population

[Preliminary Study on Etiology of Budd-Chiari Syndrome Through Clinic and Experiment].

Good Clinical Outcomes in Budd–Chiari Syndrome with Hepatic Vein Occlusion

Systemic Amyloidosis Presenting as Budd-Chiari Syndrome: A Case Report

Hepatocellular carcinoma as a complication of chronic Budd-Chiari syndrome (BCS) in a child

Interventional and Surgical Treatment of Budd-Chiari Syndrome: A Report of 39 Cases